| ²é¿´: 430 | »Ø¸´: 2 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
lx_cpuгæ (³õÈëÎÄ̳)
|
[½»Á÷]
Ê׽조¹ú¼Ê¹¤ÒµÒ©Ñ§ºÍÁÙ´²Ò©Ñ§ÑÐÌֻᡱµÄ֪ͨ£¨µÚ¶þÂÖ£©
|
||
|
¹ØÓÚ¾Ù°ìÊ׽조¹ú¼Ê¹¤ÒµÒ©Ñ§ºÍÁÙ´²Ò©Ñ§ÑÐÌֻᡱµÄ֪ͨ £¨µÚ¶þÂÖ£© ¸÷Óйص¥Î»£º ΪʹÎÒ¹úÒ½Ò©¹¤×÷Õß¼°Ê±°ÑÎÕ¹ú¼Ê¹¤ÒµÒ©Ñ§ºÍÁÙ´²Ò©Ñ§·¢Õ¹¶¯Ì¬£¬¼Ó¿ì´´ÐÂÒ©ÎïÑо¿Ó뿪·¢£¬Íƶ¯ÎÒ¹ú¹¤ÒµÒ©Ñ§¡¢ÁÙ´²Ò©Ñ§ºÍÖÎÁÆÑ§¿ÆµÄ¿ìËÙ·¢Õ¹£¬ÖÐɽ´óѧ¡¢¹ã¶«Ê¡Ò©Ñ§»á¡¢»ªÄÏÐÂÒ©´´ÖÆÖÐÐÄÓë¼ÓÄôóÂó»ù¶û´óѧ¶¨ÓÚ2009Äê10ÔÂ9ÈÕÖÁ11ÈÕÔڹ㶫ʡ¹ãÖÝÊоÙÐС°¹ú¼Ê¹¤ÒµÒ©Ñ§ºÍÁÙ´²Ò©Ñ§ÑÐÌֻᡱ¡£ ±¾»áÒ齫¹¹½¨Ò»¸ö¹ú¼Ê¹¤ÒµÒ©Ñ§ºÍÁÙ´²Ò©Ñ§½»Á÷µÄƽ̨£¬ÃÜÇÐѧÊõ½ç¡¢ÆóÒµ½ç¡¢Õþ¸®µÄÁªÏµ£¬´Ù½øÏà¹Ø²úÒµµÄ·¢Õ¹£¬¼ÓÇ¿¹¤ÒµÒ©Ñ§ºÍÁÙ´²Ò©Ñ§ÁìÓòµÄ¹ú¼ÊºÏ×÷£¬Íƶ¯ÎÒ¹úÖÆÒ©²úҵʵÏÖÓÉ·ÂÖÆÏò×ÔÖ÷´´ÐÂÑÐÖÆµÄÀúÊ·ÐÔת±ä¡£ ×éί»áÒÑÑûÇë¹úÄÚÍâ´Óʹ¤ÒµÒ©Ñ§ºÍÁÙ´²Ò©Ñ§ÁìÓòµÄר¼Ò½øÐÐѧÊõÑÐÌÖ£¬»¶Ó¸÷Óйص¥Î»Óë»á½»Á÷¡£ ÓйØÊÂÏî֪ͨÏê¼û¸½¼þ¡£ ¹ú¼Ê¹¤ÒµÒ©Ñ§ºÍÁÙ´²Ò©Ñ§ÑÐÌÖ»á×éί»á£¨´úÕ£© 2009Äê9ÔÂ16ÈÕ ¸½¼þ Ò»¡¢»áÒé×éÖ¯ Ö÷°ìµ¥Î»£ºÖÐɽ´óѧ ¹ã¶«Ê¡Ò©Ñ§»á »ªÄÏÐÂÒ©´´ÖÆÖÐÐÄ ¼ÓÄôóÂó»ù¶û´óѧ ³Ð°ìµ¥Î»£ºÖÐɽ´óѧҩѧԺ ¹ã¶«Ê¡Ò©Ñ§»áÖÆ¼ÁרҵίԱ»á ¹ã¶«Ê¡¸ßУ´´ÐÂÒ©ÎïÖÆ¼Á¹¤³Ì¼¼ÊõÑо¿ÖÐÐÄ ¼ÓÄôóÂó»ù¶û´óѧҽÁÆÖÐÐÄ ´ó»áÖ÷ϯ£º³ÂÐÂ×ÌԺʿ£¬James W. McGinity ´ó»áѧÊõίԱ»á Ö÷ÈÎίԱ£ºÖܺêå°ÔºÊ¿£¬Áõ²ýТԺʿ ¸±Ö÷ÈÎίԱ£º¶Å¹Ú»ª¡¢ÍõÄþÉú¡¢ÑÕ¹âÃÀ¡¢»Æ Ãñ¡¢Guru Betageri ίԱ£º³Â Т¡¢¹ùÏþµÏ¡¢½ð ·½¡¢Áõ »¢¡¢ÁõÅàÇì¡¢ÁõÏþÓ¬ ì¿¡¢Ã·Ð˹ú¡¢ÅËÎÀÈýƽÆäÄÜ¡¢É꾩½¨¡¢Ëï º×¡¢Ëï Ñ·¡¢Îâ ΰ¡¢Ó¡´º»ª¡¢ÔÀ ½ø¡¢ÖÓÃ÷¿µ¡¢Öܽ¨Æ½ Hak-Kim Chan, Joel Moss, Michael A. Repka, Rongtuan Lin, Albert Wai-Kit Chan, Richard Y. Ho, Scott M Wheelwright, Mingyao Liu, Ningling Wang, Grace Wong, Ilho Kim, Seiji Shibasaki, Tianru Jin, Takashi Yamaki ¶þ¡¢²¿·Ö´ó»á±¨¸æ ³ÂÐÂ×ÌԺʿ£¬ÖÐɽ´óѧҩѧԺ ÃûÓþÔº³¤ Ö»¶Ó´Ç Áõ²ýТԺʿ£¬Ìì½òÖÐÒ½Ò©´óѧ ÖÐҩѧԺԺ³¤ ÌâÄ¿£ºÌâÄ¿´ý¶¨ Öܺêå°ÔºÊ¿£¬ÖÐÄÏ´óѧÁÙ´²Ò©ÀíÑо¿ËùËù³¤ ÌâÄ¿£ºÌâÄ¿´ý¶¨ ÒÔϰ´ÐÕÊÏ×Öĸ˳ÐòÅÅÁÐ Betageri, Guru Professor and Chair of Pharmaceutical Sciences, Western University of Health Science, USA ÌâÄ¿£ºApplication of Nanoparticles for Cancer Therapy and Diagnostics Chan, Albert Wai-Kit Professor of The City University of New York, USA ÌâÄ¿£ºIntellectual Property Considerations of Industrial Pharmaceutics and Clinical Pharmacology Chan, Hak-Kim Professor in Pharmaceutics, University of Sydney, Australia ÌâÄ¿£ºThe Development of Mannitol for Iinhalation as a Successful Commercial Product Chen, Jiwen Principal Scientist of Bristol-Myers Squibb ÌâÄ¿£ºThe Evolving Role of Personalized Medicine in Healthcare ¶Å¹Ú»ª Öйúҽѧ¿ÆÑ§ÔºÒ©ÎïÑо¿Ëù¸±Ëù³¤£¬Ò©ÎïɸѡÖÐÐÄÖ÷ÈΣ¬½ÌÊÚ ÌâÄ¿£ºÌâÄ¿´ý¶¨ Ferguson, Alesia Environmental and Occupational Health College of Public Health, UAMS, USA ÌâÄ¿£ºLooking at Adherence to the Human Skin for Chemical Uptake: Use of a Computer Controlled Mechanical Chamber. Ganguly, Sid Associate Professor of Medicine Division of Hematology/Oncology University of Kansas Medical College Cancer Center, USA ÌâÄ¿£ºLow-dose Cidofovir in the Treatment of Symptomatic BK Virus Infection in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Ge, Albert Associate Director Novartis Develop New Product Through Open Innovation ÌâÄ¿£ºDevelop New Product Through Open Innovation Guo, Xiaodi Executive Vice President of Huahai US Inc. ÌâÄ¿£ºUS Generic Product Development, Registration and Approval Ho, Richard Y Director, Mfg. Technologies Bristol-Myers Squibb Co ÌâÄ¿£ºPharmaceutical Technology & Technical Transfer for New Product Registration and Product Launch »Æ Ãñ ÖÐɽ´óѧҩѧԺԺ³¤£¬½ÌÊÚ ÌâÄ¿£ºÌâÄ¿´ý¶¨ ½ð ·½ ÉϺ£Ò½Ò©¹¤ÒµÑо¿Ôº½ÌÊÚ£¬Ö÷ÈÎ ÌâÄ¿£ºÖйúÎüÈëÖÆ¼ÁµÄ·¢Õ¹Ó빤ҵ»¯ Jin, Tianru Associated professor Faculty of Medicine, University of Toronto ÌâÄ¿£ºMechanisms Underlying the Expression and Function of the Therapeutic Hormone Glucagons-like Peptide-1 Kim, Ilho GCOE Researcher, Kyoto University ÌâÄ¿£ºRemoval of Residual Pharmaceuticals in Wastewater with Physicochemical Wastewater Treatment Processes Liu, Hu Professor School of Pharmacy, Memorial University of Newfoundland, Canada ÌâÄ¿£ºTargeted Delivery of Diagnostic Drugs for Early Detection of Atherosclerosis Liu, Mingyao Professor and Director, University of Health Network ÌâÄ¿£ºSelf-Assembly Peptide Based Nano-drug Delivery ÁõÏþÓî Õ㽺£Õý¼¯ÍÅÓÐÏÞ¹«Ë¾¼¼ÊõÖÐÐÄÖ÷ÈÎ ÌâÄ¿£ºA Noval Perixosome Proliferator-activated Receptor Delta Agonist HS060098, Improving Both Dislipidemia and Obesity ¬ ì¿ ±±¾©´óѧҩѧԺ½ÌÊÚ ÌâÄ¿£º»·æßËØA/Ëû¿ËĪ˾µÄȺÌåÒ©ÎﶯÁ¦Ñ§Ä£ÐÍÓëÁÙ´²¸öÌ廯¸øÒ© ÷Ð˹ú ¾üÊÂҽѧ¿ÆÑ§Ôº¶¾ÎïÒ©ÎïÑо¿Ëù£¬Ö÷ÈÎ ÌâÄ¿£ºÒ½Ò©ÆóÒµÐÂÒ©Ñз¢Ä£Ê½Ñ¡ÔñÓë²ßÂÔ Miwa, Yoshikazu Assistant professor Department of Clinical Pharmacology, Kyushu University, Japan ÌâÄ¿£ºRole of Aldosterone on the Oxidative Stress Generation in the Vascular Wall. Possibility of Aldosterone Receptor Antagonist Moss, Joel Vice Chief of Translational Medicine Branch, NHLBI, Chair of institutional Review Board of NHLBI/NIH. ÌâÄ¿£ºClinical Research: How to Prepare for the Next Decade Onoue, Satomi School of Pharmaceutical Sciences, University of Shizuoka ÌâÄ¿£ºNovel Formulation Technologies for Improving Therapeutic Potential of Peptides/Proteins ÅËÎÀÈý ÉòÑôÒ©¿Æ´óѧҩѧԺ½ÌÊÚ ÌâÄ¿£ºÌâÄ¿´ý¶¨ ƽÆäÄÜ ÖйúÒ©¿Æ´óѧҩѧԺ½ÌÊÚ ÌâÄ¿£ºBCS2Ò©Îï×Ô΢ÈéµÄ¹ÌÌ廯¼°ÆäÈܳö¶ÈÓëÉúÎïÀûÓöÈÑо¿ Repka, Michael A Professor of Pharmaceutics, School of Pharmacy, The University of Mississippi ÌâÄ¿£ºUse of Polymer Blends for Pharmaceutical Applications Sawaki, Akira Physician-in-Chief, Department of Gastroenterology Aichi Cancer Center Hospital ÌâÄ¿£ºSignificance of Chemoradiation for Locally Advanced Pancreatic Cancer Shibasaki, Seiji School of Pharmacy Hyogo University of Health Sciences ÌâÄ¿£ºMolecular Display S ystem Provides Powerful Tool for the Screening of Therapeutic Proteins Ëï º× Ìì½òÌìÊ¿Á¦¼¯ÍŸ±×ܲà ÌâÄ¿£ºÁÙ´²Ò©Ñ§ÔÚÐÂÒ©Ñз¢Óë¹ÜÀíÖеÄÓ¦Ó᪡ªFDA¾Ñé̸ Ëï Ñ· ËÄ´¨´óѧ»ªÎ÷ҩѧԺ½ÌÊÚ ÌâÄ¿£ºÑª¹ÜÄÚ×¢ÉäÓø¨ÁϵÄÑо¿ Takashi Azuma Kyoto University, JAPAN ÌâÄ¿£º Occurrence of Pharmaceuticals and Personal Care Products in the Water Environment Wang, Ningling Partner Finnegan, Henderson, Farabow, Garrett & Dunner, LLP ÌâÄ¿£ºObtaining Winning Patents for FDA Orange Book Wei, Bill ҩѧԺ¿Í×ù½ÌÊÚ£¬ ÃÀ¹úÐÂÔóÎ÷ÖÝRugters´óѧ ÌâÄ¿£ºÐÂÐÍÒ©ÎïÖÆ¼Á²úÆ·ÔÚ¹ú¼ÊÊг¡µÄ»ú»á Wheelwright, Scott M President and CEO, Asia Specialist Strategic Manufacturing Worldwide, Inc ÌâÄ¿£ºBringing Pharmaceutical Products to Market in the United States Wong, Grace Founder, Chief Scientific Officer & President ActoKine Therapeutics ÌâÄ¿£ºIdentification of AK-1 for Radioprotection and AK-2 for Protection Against A Broad- spectrum Viral Infection Îâ ΰ ¸´µ©´óѧҩѧԺ¸±Ôº³¤£¬½ÌÊÚ ÌâÄ¿£ºFluid-bed Coating as a New Technique to Prepare Solid Dosage Forms From Liquids Xia, Mingde Senior Director, Johnson & Johnson COSAT SAPA President, 2008-2009 ÌâÄ¿£ºJohnson & Johnson's Open Innovation Strategy Yamaki, Takashi Department of Plastic and Reconstructive Surgery, Tokyo Women¡¯s Medical University ÌâÄ¿£ºCombined Use of Pretest Clinical Probability Score and Latex Agglutination D-dimer Testing for Excluding Acute Deep Vein Thrombosis ÑÕ¹âÃÀ ÖÐɽ´óѧ¸±Ð£³¤»ªÄÏÐÂÒ©´´ÖÆÖÐÐÄÖ÷ÈÎ ÌâÄ¿£º»ªÄÏÐÂÒ©´´ÖÆÖÐÐĽ¨Éè¹æ»® Yang, Xiaowei Division of Biostatistics, Department of Public Health Sciences, University of California, USA ÌâÄ¿£ºAnalysis of Incomplete Longitudinal Data with Binary Outcomes Yasojima, Makoto Associate Professor, Graduate School of Engineering, Kyoto University ÌâÄ¿£ºA New Social Concern, Pharmaceuticals as Water Environmental Pollutant Ó¡´º»ª ¸´µ©´óѧÉúÃü¿ÆÑ§Ñ§Ôº½ÌÊÚ. ÌâÄ¿£ºChitosan-based Nanocarriers for Iimproved Drug Delivery ÔÀ ½ø ʯ¼Ò×¯ÖÆÒ©¼¯ÍÅÖ´ÐÐ×ܲà ÌâÄ¿£ºÐÂÐÎÊÆÏµĹúÄÚÒ½Ò©²úÒµ´´ÐÂ̽Ë÷ Öܽ¨Æ½ ÖйúÒ©¿Æ´óѧҩ¼Áѧ½ÌÑÐÊÒÖ÷ÈÎ ÌâÄ¿£ºÏÖ´úÒ©¼ÁѧÑо¿½øÕ¹ Zhang,Dong Staff Scientist ICBB-Pfizer ÌâÄ¿£ºExploring De-ubiquitination Enzymes (DUB) as Novel Anti-cancer Therapy Targets Zhou, Charlie Team Leader, Perrigo Pharmaceutical Company ÌâÄ¿£ºStrategies and Approaches to Modernization of Chinese Materia Medica Zhou, Ming-Sheng University of Miami Miller School of Medicine, USA ÌâÄ¿£ºMechanism Underlying Statins Mitigation of Cardiovascular and Renal Injury in Salt-sensitive Hypertension. Èý¡¢´ó»á×éί»á Ö÷ÈÎίԱ£ºÎâ´«±ó ¸±Ö÷ÈÎίԱ£º³Â Т¡¢Õſ˼ᡢµË½£ÐÛ¡¢Â½ Ò£ ίԱ£º²ÌÉܻԡ¢³Â½¨º£¡¢³Â³ԡ¢³ÂÑàÖÒ¡¢³ÂÕñµÂ¡¢³Ì¹ú»ª¡¢·ë Ãô¡¢·ëÎÄÖÜ¡¢¸ß³ç¿¡¢ ºÎÑÞÁá¡¢ºîÁ¬±ø¡¢»Æºì±ø¡¢¼¾°®Ãñ¡¢Àî¹ú³É¡¢ÀèÊïϼ¡¢ÀîÔ˾°¡¢ÁõÊÀÃ÷¡¢ÂíÏþð¿¡¢ ʯ ÀÚ¡¢Ì·ÊØÓ¡¢Ìƺé÷¡¢Îâ ÁÕ¡¢ÎâÏþÁá¡¢ÎâÏþËÉ¡¢ÎâÐÂÈÙ¡¢Ð¤º£Åô¡¢Ð¤ÏæÁÖ¡¢ ÐìÔº졢ÑÏÅô¿Æ¡¢Ñî´úºê¡¢Ñî ·«¡¢Ñî Ãô¡¢Ò¶Àö¿¨¡¢ÓàÃô±ó¡¢ÕÅÓÀÃ÷¡¢ÕÅÖÒÒå¡¢ Ö£Ö¾»ª¡¢Öì¹â׿¡¢ÖìÉÙè¯ ËÄ¡¢»áÒéʱ¼äµØµã ʱ¼ä£º2009Äê10ÔÂ9ÈÕ-11ÈÕ£¨9ÈÕÈ«Ì챨µ½£© µØµã£º¹ãÖݹúµÂ¹ú¼Ê´ó¾Æµê£¨¹ãÖÝÊÐÌìºÓ¶«Â·153ºÅ¹úµÂ´óÏã© ³Ë³µÂ·Ïߣº 1. ´Ó¹ãÖݰ×ÔÆ¹ú¼Ê»ú³¡(лú³¡)»ú³¡¿ìÏßB³Ë³µÇø×ø¿Õ¸Û¿ìÏß2ºÅÏßB(»ú³¡ÖÁԣͨ´ó¾Æµê)ÖÁ»ú³¡¿ìÏß×Üͳ´ó¾Æµê£¬µ½Âí·¶ÔÃæµÄ¸Ú¶¥Õ¾2ת³Ë298·ÖÁÌìºÓ¶«Â·Õ¾¡£Ï³µ×ßÔ¼320Ãס£ 2. ´Ó¹ãÖÝ»ð³µÕ¾×ÜÕ¾×ø234·»ò33·µ½¸Ú¶¥Õ¾1£¬Ï³µ×ßÔ¼540Ãס£ Îå¡¢»áÎñ·ÑÓ㺠800Ôª/ÈË£¬ÔÚ¶Á²©Ê¿¼°Ë¶Ê¿Ñо¿Éú400Ôª/ÈË£¨Æ¾ÓÐЧѧÉúÖ¤¡¢Éí·ÝÖ¤£©¡£ ±¸×¢£º×¡ËÞ»áÎñ×éͳһ°²ÅÅ£¬·ÑÓÃ×ÔÀí¡£ Áù¡¢Ê³ËÞ°²ÅÅ 1. סËÞ°²ÅÅ£¨×ÔԸѡÔñ£© ¹ãÖݹúµÂ¹ú¼Ê´ó¾Æµê£¨ÎåÐǼ¶£© µØµã£º¹ãÖÝÊÐÌìºÓ¶«Â·153ºÅ¹úµÂ´óÏà ºÀ»ªË«ÈË·¿£º 420ÈËÃñ±Ò/¼ä/Ìì 2. ×éί»á½«ÎªÓë»á´ú±íͳһ°²ÅÅ10ÔÂ9ÈÕÍí²ÍÖÁ11ÈÕÍí²Í£¬Óò͵ľßÌåʱ¼äºÍµØµã½«ÁíÐÐ֪ͨ¡£Óë»á´ú±í½«ÔÚ×¢²áʱÁìÈ¡²Íȯ£¬Æ¾È¯Óòͣ¬Ê£Óà²Íȯ²»Í˿ Æß¡¢ÁªÏµ·½Ê½£º µØ Ö·£ºÖйú¹ã¶«Ê¡¹ãÖÝÊдóѧ³ÇÍâ»·¶«Â·132ºÅÖÐɽ´óѧҩѧԺ ÓÊ ±à£º510006 µç »°£º020-39943120 ÊÖ »ú£º13539753131 ´« Õæ£º020-39943119£¬020-39943120 Áª ϵ ÈË£º°×ѩȺ µç×ÓÓÊÏ䣺IPCP2009@yahoo.com.cn |
» ²ÂÄãϲ»¶
Ò»Ö¾Ô¸±±¾©»¯¹¤´óѧ²ÄÁÏÓ뻯¹¤£¨085600£©296Çóµ÷¼Á
ÒѾÓÐ23È˻ظ´
08¹¤¿Æ£¬295£¬½ÓÊÜ¿çרҵµ÷¼Á
ÒѾÓÐ3È˻ظ´
²ÄÁÏѧ˶333Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
334·Ö Ò»Ö¾Ô¸ÎäÀí ²ÄÁÏÇóµ÷¼Á
ÒѾÓÐ16È˻ظ´
0703»¯Ñ§321·ÖÇóµ÷¼Á
ÒѾÓÐ9È˻ظ´
²ÄÁÏר˶ 085600Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
297Çóµ÷¼Á
ÒѾÓÐ15È˻ظ´
11408×Ü·Ö309£¬Ò»Ö¾Ô¸¶«ÄÏ´óѧÇóµ÷¼Á£¬²»Ìôרҵ
ÒѾÓÐ5È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
»¯¹¤×¨Ë¶Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
472514568
ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)
Сľ³æÒéÕþ´ó³¼¼æÐ°ì´óѧʿ
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ¹ó±ö: 1.371
- ½ð±Ò: 16270.8
- É¢½ð: 25
- ºì»¨: 6
- ɳ·¢: 1
- Ìû×Ó: 3289
- ÔÚÏß: 224.2Сʱ
- ³æºÅ: 713538
- ×¢²á: 2009-03-03
- ÐÔ±ð: GG
- רҵ: ÁÙ´²Ò©Àí

2Â¥2009-10-10 14:21:29
3Â¥2009-10-10 14:42:23














»Ø¸´´ËÂ¥